FDA Approves New Restless Legs Syndrome Drug Horizant

The FDA has approved a new drug called Horizant to treat moderate-to-severe restless legs syndrome.

Click here to read the full story.

Post a Comment
 

 
Comments
No comments yet!
Inergize Digital This site is hosted and managed by Inergize Digital.
   

WTVQ.com supports children's privacy rights. All persons under the age of 13 MUST have parental permission to use this website and direct parental supervision is strongly recommended.